- Former VA Secretary argues the Veterans Health Administration can boost US biotech competitiveness against ChinaThe piece, authored by former Veterans Affairs Secretary David Shulkin, positions the VA as a critical component of America’s biotechnology ecosystem alongside HHS and the Department of Defense. H…
- STAT+: FDA expert committee reviews Capricor Therapeutics’ Duchenne drugSTAT is live-blogging an FDA meeting on Capricor Therapeutics’ treatment for Duchenne muscular dystrophy, which has been the subject of a contentious regulatory review.